Yes. I’d separate “safest protocol infrastructure” from “safest trader to copy”—those are very different questions.
After checking current protocol docs, security history, and live-ish ecosystem metrics, my ranking for a social trader would be:
| Protocol / model | My take | Track record | Main risk |
|---|
| Enzyme | 🟢 Best overall for conservative on-chain managed portfolios | 6+ years; ~$90M TVL; 4,400+ historical/current vaults | Manager + strategy risk |
| Chamber / dHEDGE | 🟢 Excellent, particularly for transparent managed vaults | Live since 2020; ~$37M current TVL | Individual manager / leverage risk |
| Hyperliquid native vaults | 🟢 Best newer option for active/perps traders | Significant live trading history; native infrastructure | Perps/leverage + trader blow-up risk |
| Set Protocol / Index Coop | 🟢 Very strong infrastructure, but less “social copy trading” today | Multi-year; heavily audited; major index products | Strategy/product-specific risk |
| Nested | 🟡 Interesting actual copy-trading UX, but I'd rank it below the above | 30k+ portfolios, but comparatively weak current economic footprint | Protocol/admin + copy-strategy risk |
| Copycat | 🔴 Would not rank as a serious safety-first choice | Historical product/audits, but weak current evidence | Longevity, liquidity, smart-contract/token ecosystem |
1. Enzyme — probably my #1 for safety + longevity
Enzyme Finance is closer to an on-chain hedge-fund/vault infrastructure layer than a Twitter-style copy-trading platform.
The important part is the architecture: investors deposit into vault contracts rather than sending assets directly to the manager. Enzyme says it has $82M+ AUM, 4,400+ vaults and 9,300+ depositors, while its current protocol stats show roughly $90M TVL.
It also has an unusually long history for this category: Enzyme describes itself as having six-plus years of mainnet track record, and its infrastructure has been used for managed portfolios and tokenized funds.
Most importantly for me, Enzyme has explicit risk controls around what assets, protocols and price feeds a vault can interact with.
Verdict: If you're willing to sacrifice some of the slick social/copy-trading experience in exchange for mature infrastructure, this is one of the first places I'd look.
2. Chamber / dHEDGE — arguably the most interesting social-manager infrastructure
Chamber (formerly dHEDGE) is particularly relevant to your question.
It has been live since August 2020, and dHEDGE reports audits from CertiK and Iosiro plus a continuing bug bounty. Its model is explicitly non-custodial: managers can trade the assets but don't have the ability to simply withdraw the underlying pool assets.
Current Chamber statistics show roughly:
- $36.7M TVL
- 3,700+ vaults
- 2,250+ managers
- ~$4M manager fees earned
- ~$440K DAO fees earned
That's meaningful real-world history, rather than merely a protocol with a nice website.
And the leaderboard is particularly useful for a social trader: it ranks pools using risk-adjusted performance (Sortino) and AUM, rather than simply "highest return."
That's a very important distinction. A wallet that made +500% with $2,000 and 90% drawdown shouldn't automatically outrank a manager producing +40% with $5M and controlled risk.
Verdict: My favorite pure social/managed-vault architecture, particularly if you screen managers yourself.
3. Hyperliquid native vaults — strongest option for active trader copying
Hyperliquid is different from Enzyme/dHEDGE.
Its native vault system lets anyone deposit into a trader-managed vault and share in its P&L; the vault manager receives 10% of profits for user vaults. Hyperliquid explicitly tells users to assess the vault's performance history and risk before depositing.
The nice property here is that you're not relying on a third-party copy bot to watch someone's wallet and replicate transactions. The vault is part of the trading infrastructure.
You can inspect things such as:
- P&L
- maximum drawdown
- volume
- open positions
- trade history
- number/duration of depositors
through the vault interface.
There is also a 5% minimum manager skin-in-the-game requirement for vault leaders in the legacy/native model.
The downside is substantial: most interesting Hyperliquid strategies are perpetual-futures strategies, so protocol safety doesn't make the underlying strategy safe.
A brilliant trader can still lose 80% overnight.
Verdict: For copying actual active traders, I'd put Hyperliquid vaults ahead of Nested/Copycat, but I'd impose much stricter drawdown and leverage filters.
4. Set Protocol / Index Coop — safest infrastructure, but not really social trading
Index Coop's products have historically used Set Protocol v2, including DPI, MVI, BED, icETH and leveraged FLI products.
This is probably the strongest answer if by "safe" you mean mature smart-contract infrastructure rather than "best trader to follow."
Set/Index has accumulated extensive independent security review. Index lists audits from OpenZeppelin, ABDK, Iosiro, Code4rena and Sherlock covering the core contracts/modules and various extensions.
But there's an important conceptual distinction:
Set is portfolio automation/infrastructure, not really a trader-social network.
So I'd use it for:
"I want transparent, programmable exposure to a strategy."
rather than:
"I want to find a great human trader and copy them."
Verdict: 🟢 Very high infrastructure confidence; mediocre fit for your exact social-trading use case.
Where I'd put Nested
Nested Finance is actually much closer to what you're asking for.
Its model is explicitly:
find trader → inspect portfolio → copy portfolio → optionally follow subsequent changes.
Nested says it has 30,000+ portfolios and lets users inspect other traders' portfolios and copy their allocations.
The copy mechanism is also genuinely non-custodial: your copy belongs to you, rather than becoming an asset controlled by the original trader.
That's good.
However, I wouldn't put it in the same safety tier as Enzyme/Chamber yet.
Its own documentation acknowledges that smart-contract upgrades involve privileged functions and that maintenance engineers can pause/unpause contracts; it also describes multisig/timelock controls.
More importantly, the economic footprint appears much smaller today. Current DeFiLlama data puts Nested at only around $155K TVL, versus tens of millions for Enzyme/Chamber.
That's a huge difference when you're evaluating meaningful track record.
Verdict: 🟡 Legitimate and conceptually interesting, but not my first choice for significant capital.
Copycat: I'd avoid for serious capital
Copycat is an interesting historical example of exactly the architecture you're talking about. Its V2 launched decentralized copy trading/farming and had PeckShield auditing, alongside other security reviews.
But that's not enough for my definition of "safe."
The current project has evolved into a different PVPAMM/PNL-pool/BRC20 DEX product, rather than being the mature copy-trading ecosystem its earlier documentation describes.
The historical docs also show a relatively small bug bounty—up to $5K for critical findings—and the important copy-trading documentation is several years old.
So:
Audited ≠ battle-tested.
And:
Old product documentation ≠ current operational track record.
Verdict: 🔴 I wouldn't choose Copycat over Enzyme, Chamber or Hyperliquid if capital preservation is the priority.
The bigger issue: "copy trading" itself is risky
This is where I would be more conservative than most crypto social-trading platforms.
There are at least four different risks:
- Protocol risk — smart contract gets exploited.
- Manager risk — trader loses money.
- Execution risk — your copy gets a worse entry/exit than theirs.
- Selection risk — you pick a trader whose historical returns were mostly luck, leverage, illiquid tokens, or survivorship bias.
The fourth is particularly nasty.
Research has demonstrated that public blockchain activity makes profitable strategies observable and potentially copyable/front-runnable; one study found substantial potential profits from automated imitation of transactions.
And recent work specifically on crypto copy trading highlights manipulative bots, uncertain future trader performance and execution lag as major problems.
So I wouldn't select a trader simply because:
+427% lifetime return
I'd want something closer to:
3+ years history + substantial AUM + multiple market regimes + low/controlled max drawdown + meaningful manager capital + no obvious token manipulation + transparent on-chain fills.
My practical ranking
If I were allocating my own risk budget, I'd roughly classify the ecosystem as:
🟢 Tier 1 — investigate seriously
Chamber/dHEDGE
Best combination of longevity, non-custodial architecture, manager marketplace and risk-adjusted performance data.
Enzyme
Best mature infrastructure for managed on-chain portfolios, especially if you care more about safety than social features.
Hyperliquid native vaults
Best fit if what you actually want is following active/perps traders and you're comfortable with much higher strategy risk.
🟡 Tier 2 — interesting but smaller/newer
Nested
The closest match to classic "social portfolio copying," but its current capital footprint makes me substantially less comfortable putting serious money there.
🔴 Tier 3 — I wouldn't use for serious capital
Copycat-style BSC-era copy-trading protocols
The combination of small/dated ecosystems, token incentives, weaker current evidence and rapidly changing products isn't attractive relative to the alternatives.
One distinction I'd make very strongly
If you're looking for "Who should I copy?", I would actually start with Chamber/dHEDGE and Hyperliquid, not with protocols branded as copy-trading protocols.
The irony is that the safest architecture tends to look less like:
"Give us money and automatically copy this influencer."
and more like:
"Deposit into a constrained vault whose manager's actions are observable on-chain and whose permissions are enforced by smart contracts."
That's a much better risk model.
If you want, I can take this one step further and do a 2026 due-diligence ranking of the actual top 10 on-chain traders/vaults to follow across Chamber/dHEDGE, Enzyme and Hyperliquid, scoring each on 3Y/1Y returns, max drawdown, Sharpe/Sortino, AUM, manager skin-in-the-game, leverage, liquidity, fees and smart-contract risk. That would be considerably more useful than simply ranking the protocols.